Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. - Wikidata - thesis-toulmin - TriplyDB

Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.

Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.

http://www.wikidata.org/entity/Q33901939

about

The complete genome and phenome of a community-acquired Acinetobacter baumannii Proteomics As a Tool for Studying Bacterial Virulence and Antimicrobial Resistance Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data.Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections Expanding landscapes of the diversified mcr-1-bearing plasmid reservoirs.Efficacy of the small molecule inhibitor of Lipid II BAS00127538 against Acinetobacter baumannii Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin.Deciphering the magainin resistance process of Escherichia coli strains in light of the cytosolic proteome Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012.genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii.Matrix-assisted laser desorption ionization-time of flight (maldi-tof) mass spectrometry for detection of antibiotic resistance mechanisms: from research to routine diagnosis Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.Combination approaches to combat multidrug-resistant bacteria.Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii.Small-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence.Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance.Colistin and polymyxin B: peas in a pod, or chalk and cheese?Variation in the OC locus of Acinetobacter baumannii genomes predicts extensive structural diversity in the lipooligosaccharide.The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model.Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance Reinforcing Lipid A Acylation on the Cell Surface of Acinetobacter baumannii Promotes Cationic Antimicrobial Peptide Resistance and Desiccation Survival In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosa The Role of the Two-Component System BaeSR in Disposing Chemicals through Regulating Transporter Systems in Acinetobacter baumannii.High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens.Current epidemiology and growing resistance of gram-negative pathogens.Second Generation Modifiers of Colistin Resistance Show Enhanced Activity and Lower Inherent Toxicity Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606.A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii.Acquisition of Tn6018-3' CS regions increases colistin MICs against Acinetobacter baumannii isolates harboring new variants of AbaRs.Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway Comparative Genomics of Two ST 195 Carbapenem-Resistant Acinetobacter baumannii with Different Susceptibility to Polymyxin Revealed Underlying Resistance Mechanism.

P2860

Q21559675-5EE8225D-076F-4453-8E45-978F44CBA356 Q26749601-94C11A62-A4E1-47B5-8FED-0C4937FB6679 Q26771783-05EB37CB-0124-49F2-8ED8-48EC83EE76A8 Q26991886-48AA0136-D5E1-4368-AF7B-D87ECFFCAD70 Q27015109-3A2C7ACD-FB03-4365-8042-4F1D353B1FE2 Q27024893-4E205364-3570-4BD0-A979-41768B60FCB7 Q30235064-82297297-A7A2-4660-AC43-1C6421612275 Q31031386-AB33A6CD-30B1-4440-BF08-6045D25568DB Q33732524-0B68DE46-6195-47DF-9CE7-2F006A8ECB9D Q33882520-2684D9E9-9CEA-4AFF-BB94-E40175BA2A91 Q34049982-6D87123B-A0D5-4C80-9F0E-01A1B54BD625 Q34058244-11B44146-9443-469D-8FA5-D010F035780A Q34145463-DB97C6CD-7541-4801-B1E8-37D3E6041286 Q34489424-1ACB6B4A-7015-4398-841D-DE1421607239 Q34508304-6F4C8C27-1E1E-4798-910C-958A4381EE48 Q34538888-4A9F2EF9-2884-4E24-A245-A0E5805AFE1D Q34552966-BE694980-9651-4856-B778-227EE6DD4C4F Q34554879-F7846678-FF96-485E-B039-0111B1539B16 Q34632985-54D7D049-98F0-4DA3-945F-68ED8C656ADF Q34823364-21045CAB-2093-4331-A93E-AC71054FF720 Q34922881-B9AB2DF9-B4B0-48CC-BACE-73FC6BB79A05 Q35008357-A2EDF4C6-50F1-4FD5-A8DC-1E011423F72F Q35270634-3C365431-7212-4682-BDF9-3F95DEBFAAD6 Q35432662-99A42A35-B421-4E51-AB5F-0941E79608C2 Q35551122-BBF20753-6A04-4361-8641-8CD9025C89A4 Q35640103-B9E1EE6B-54AB-41E1-9152-06AE0F498B32 Q35662086-728F7111-106C-4A0C-9033-DAA7BC2D07C3 Q35666622-0D580C94-C65D-41C6-BF19-C6743366E4E6 Q35841626-3B113580-244C-4385-8156-C94B57BD8CF6 Q35843094-F0DCF441-EEBF-4E17-93ED-F7DDFDF73087 Q35905605-515ED419-ABC7-41F7-A0BB-42DAA7000905 Q36018796-300064E2-F75D-413A-97B9-91125FC4457C Q36025192-5C202159-F661-4088-A1C9-75B441E6AED7 Q36080468-075F03D9-158A-4C2C-9048-0EE14B9659DC Q36104259-1AE986FE-E36E-4992-A097-E20D34BD6AB5 Q36290794-FAE641A3-4850-4BE4-ACBA-0C719AB96A97 Q36290895-50860AD4-13B2-4336-A64D-B22E5052442F Q36335694-33986B2C-0D19-4C9B-9050-CA2FE308FAB6 Q36364121-0CE25646-9865-4EF1-BA92-1C5026C3D0B1 Q36427137-5A4E698E-29FB-48F1-B03F-21C0CFFCFBF9

P2860

Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.

http://www.wikidata.org/entity/Q33901939

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Phosphoethanolamine modificati ...... o-component regulatory system.

@ast

Phosphoethanolamine modificati ...... o-component regulatory system.

@en

type

label

Phosphoethanolamine modificati ...... o-component regulatory system.

@ast

Phosphoethanolamine modificati ...... o-component regulatory system.

@en

prefLabel

Phosphoethanolamine modificati ...... o-component regulatory system.

@ast

Phosphoethanolamine modificati ...... o-component regulatory system.

@en

P1433

Q33901939-EFC73CC8-7C41-45C7-9105-DAD74C62D675

P1476

Q33901939-E79A6131-AEE1-41FD-AA57-90292B66894A

P2093

Q33901939-2022657B-33CD-4B1C-B446-ED6C3F45672F

Q33901939-3A22CD78-2CB0-4FCB-BE6B-05B0838DF899

Q33901939-68ACE77E-6663-4375-A066-436EE5FBA175

Q33901939-76856308-5212-4779-9060-571A16EB6127

Q33901939-83BB9580-1589-4DEA-B195-D92504844518

Q33901939-B7683260-D161-4B23-B6DD-1FABBFAB96B8

Q33901939-CB10D45D-D1C6-4415-888D-AD6661DF2E26

Q33901939-D1FEE400-2692-40D6-851C-180E1F7604A6

P2860

Q33901939-055C2C20-E039-46D9-A876-04912FCFF122

Q33901939-0A4276CF-31EC-452B-A537-B00199B60E84

Q33901939-0BFA13F9-2C1D-48BF-84B2-13F4BECF3855

Q33901939-0F6BE4B1-D8CE-454C-8C91-7BC88BC4A74A

Q33901939-16932FAB-ADD5-46E1-AADA-A217BAF85AEA

Q33901939-16C2B0E2-D94D-427C-8118-2B6EE8CBCE9E

Q33901939-16CA017D-B98D-45EB-8681-9345F9CB3D16

Q33901939-26AF983B-6DD6-4D0C-845F-B3D652E9D9BD

Q33901939-2A913812-BBC1-465B-8CC6-18005639D87F

Q33901939-2B688A37-9E06-4E61-864C-8A2762FB21D2

P304

Q33901939-5B51979F-CB48-4C59-9F43-0E3AD55B7D84

P31

Q33901939-E431DB45-F7F0-49CC-BF4E-E35574B8C4E8

P356

Q33901939-75C57FB8-6393-476C-B82E-9503C845FBD9

P407

Q33901939-F4985572-F938-4FE4-9A82-2ECEBFC6C93F

P433

Q33901939-545DF4A8-447B-46E4-BE93-1C6E6DF57FDF

P478

Q33901939-BCF981E2-9B18-4F07-B5FF-7B635BAABB06

P50

Q33901939-6B30F06F-BD47-42E0-9624-5083BE0B14F4

Q33901939-9D480D1F-E81C-4A08-9168-BDA14B5D2690

Q33901939-BF3BEC0F-990A-4866-B978-D9D5A713B14A

P577

Q33901939-BE38E000-4D33-47CC-9D42-FCF638649966

P5875

Q33901939-35FC79DF-31D3-4A19-9DFD-AE7D19E0E258

P698

Q33901939-249F3297-90A5-4994-B62B-D9E525865CCC

P921

Q33901939-CCF5C036-C294-429A-A585-26D8B4E25B90

P932

Q33901939-81614E35-2915-4E05-AD72-DDC4FD0A0202

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Phosphoethanolamine modificati ...... wo-component regulatory system

@en

P2093

Alejandro Beceiro

http://www.w3.org/2001/XMLSchema#string

David M Livermore

http://www.w3.org/2001/XMLSchema#string

Enrique Llobet

http://www.w3.org/2001/XMLSchema#string

Henrik Chart

http://www.w3.org/2001/XMLSchema#string

Hiran Dhanji

http://www.w3.org/2001/XMLSchema#string

Jesús Aranda

http://www.w3.org/2001/XMLSchema#string

Michel Doumith

http://www.w3.org/2001/XMLSchema#string

Neil Woodford

http://www.w3.org/2001/XMLSchema#string

P2860

Solution structure of the homodimeric core domain of Escherichia coli histidine kinase EnvZ

Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa

Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

An inner membrane enzyme in Salmonella and Escherichia coli that transfers 4-amino-4-deoxy-L-arabinose to lipid A: induction on polymyxin-resistant mutants and role of a novel lipid-linked donor.

A triple mutant of Escherichia coli lacking secondary acyl chains on lipid A.

Detailed characterization of the lipid A fraction from the nonpathogen Acinetobacter radioresistens strain S13.

Dissection of host cell signal transduction during Acinetobacter baumannii-triggered inflammatory response

A rapid and simple method for constructing stable mutants of Acinetobacter baumannii

Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity.

P304

3370-3379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00079-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

José Antonio Bengoechea

Michael Hornsey

P577

2011-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51130769

http://www.w3.org/2001/XMLSchema#string

P698

21576434

http://www.w3.org/2001/XMLSchema#string

P921

Acinetobacter baumannii

P932

3122444

http://www.w3.org/2001/XMLSchema#string